oral melatonin in the treatment of acute respiratory distress syndrome

Phase 3

Recruiting

• Conditions: Distress syndrome of neonates.; P22.0Respiratory distress syndrome of newborn; P22.0

• Registration Number: IRCT20130308012743N3
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

Infants with respiratory distress syndrome with any grade of respiratory distress

Exclusion Criteria

Neonatal sepsis
Neonates with Respiratory distress disease other than RSD
Neonates with cardiovascular diseases or diseases of the central nervous system
Neonates with kidney failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pro-antioxidant. Timepoint: Laboratory examination is done on the first and third day of birth. Method of measurement: By measuring pro-antioxidant test.;C-reactive protein factor (CRP). Timepoint: Laboratory examination is done on the first and third day of birth. Method of measurement: By measuring CRP.;Respiratory distress score. Timepoint: Laboratory examination is done on the first and third day of birth. Method of measurement: By Measuring Respiratory distress score.